GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FluoroPharma Medical Inc (OTCPK:FPMI) » Definitions » 5-Year Dividend Growth Rate

FluoroPharma Medical (FluoroPharma Medical) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2016)


View and export this data going back to 2008. Start your Free Trial

What is FluoroPharma Medical 5-Year Dividend Growth Rate?

FluoroPharma Medical's Dividends per Share for the three months ended in Dec. 2016 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

FluoroPharma Medical's Dividend Payout Ratio for the three months ended in Dec. 2016 was 0.00. As of today, FluoroPharma Medical's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of FluoroPharma Medical's 5-Year Dividend Growth Rate

For the Biotechnology subindustry, FluoroPharma Medical's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FluoroPharma Medical's 5-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FluoroPharma Medical's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where FluoroPharma Medical's 5-Year Dividend Growth Rate falls into.



FluoroPharma Medical 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


FluoroPharma Medical  (OTCPK:FPMI) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

FluoroPharma Medical's Dividend Payout Ratio for the quarter that ended in Dec. 2016 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2016 )/ EPS without NRI (Q: Dec. 2016 )
=0/ -0.027
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FluoroPharma Medical 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of FluoroPharma Medical's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


FluoroPharma Medical (FluoroPharma Medical) Business Description

Traded in Other Exchanges
N/A
Address
8 Hillside Avenue, Suite 108, Montclair, NJ, USA, 07042
FluoroPharma Medical Inc is a US-based biopharmaceutical company. It specializes in developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The company focuses on the development of novel cardiovascular imaging agents which detect and assess acute and chronic forms of coronary artery disease (CAD). The company's clinical-stage molecular imaging pharmaceutical product candidates are 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). The 18-F TPP is designed for use in stress-testing for patients with proven CAD whereas 18-F FCPHA is a molecular imaging agent which is designed to assess myocardial blood flow and metabolism in patients with CAD. The company operates in a single segment being Biopharmaceutical research and development.
Executives
Johan M. Spoor director, officer: CEO, PRESIDENT, CHAIRMAN 500 BOYLSTON STREET, SUITE 1600, BOSTON MA 02116

FluoroPharma Medical (FluoroPharma Medical) Headlines

From GuruFocus